Advertisement

Topics

Gilead Sciences Inc. Company Profile

06:23 EDT 18th April 2019 | BioPortfolio

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.


News Articles [1196 Associated News Articles listed on BioPortfolio]

Gilead Sciences-Aktie sieht attraktiv aus!

Toronto (www.aktiencheck.de) - Gilead Sciences-Aktienanalyse von Analyst Matthew Luchini von BMO Capital Markets: Laut einer Aktienanalyse in Bezug auf den US-Biotechkonzern Gilead Sciences Inc. (I...

Gilead Sciences Announces Fourth Quarter 2018 Dividend

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the fourth quarter...

Gilead Sciences Announces 11 Percent Increase in First Quarter 2019 Dividend

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 11% in the company’s quarterly cash dividend, beginning ...

AELIX Therapeutics and Gilead Sciences to trial HIV therapy

AELIX Therapeutics and Gilead Sciences have entered a joint clinical research collaboration for the analysis of proprietary investigational products. Called AELIX-003,...Read More... The post AELIX T...

Gilead Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7

Webcast Available Through Gilead Corporate Website Gilead Sciences, Inc. (Nasdaq: GILD) today announced that members of the executive management team will participate in a fir...

Gilead Sciences Names Daniel O'Day Chairman and Chief Executive Officer

-- Mr. O'Day Brings Global Pharmaceutical Leadership Experience Across Geographies and Therapeutic Areas -- -- Appointment Effective March 1, 2019 -- Gilead Sciences, Inc. (Nasdaq: GILD) announced...

Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27

Webcast Available Through Gilead Corporate Website Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L. Washington, Gilead’s Executive Vice President and Chief...

Gilead Sciences to Present at the Barclays Global Healthcare Conference on Tuesday, March 12

Webcast Available Through Gilead Corporate Website Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L. Washington, Gilead’s Executive Vice President and Chief...

Drugs and Medications [59 Associated Drugs and Medications listed on BioPortfolio]

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

Sovaldi access [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. GILEAD ACCESS PROGRAM SOVALDI™ (sofosbuvir) tablets, f...

Harvoni access [gilead sciences, inc]

These highlights do not include all the information needed to use HARVONI™ safely and effectively. See full prescribing information for HARVONI. HARVONI (ledipasvir and sofosbuvir) tablets, for oral...

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Clinical Trials [233 Associated Clinical Trials listed on BioPortfolio]

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir and Ledipasvir from M...

A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Magicbuvir 400 m...

A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Elbanovir 400 mg...

Companies [1102 Associated Companies listed on BioPortfolio]

Gilead Sciences Canada, Inc.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to...

Gilead Sciences Inc.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company s...

Gilead Sciences, Inc. and Boehringer Ingelheim

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to adva...

Gilead Sciences, Inc.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to adva...

Gilead Sciences

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions forpatients and the people who care for them. The Company discovers, develops and commerci...

More Information about "Gilead Sciences Inc." on BioPortfolio

We have published hundreds of Gilead Sciences Inc. news stories on BioPortfolio along with dozens of Gilead Sciences Inc. Clinical Trials and PubMed Articles about Gilead Sciences Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gilead Sciences Inc. Companies in our database. You can also find out about relevant Gilead Sciences Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record